Delivery Order SPE2DR25D3303-SPE2DR26F65D0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,187.99 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This non-set-aside, firm fixed-price delivery order has a ceiling value of $3,177.01 and is scheduled for completion by December 10, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) with a ceiling value of $3,311.13. This contract employs firm fixed-price pricing and is scheduled for ultimate completion by December 8, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract carries a ceiling value of $2,653.44 and employs firm fixed pricing, with an ultimate completion date of December 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,688.16 to AmerisourceBergen Drug Corp for 100 tablets of Azathioprine 50 mg, with an ultimate completion date of December 9, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $5,064.48. The delivery order, which is non-set-aside and competitively awarded, has an ultimate completion date of December 5, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Azathioprine 50 mg, a firm fixed price contract valued at $2,022.10. The order was competitively awarded without set-aside designation and has an ultimate completion date of December 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) at a ceiling value of $1,325.90. This is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) under a firm fixed-price contract valued at $2,401.99, with an ultimate completion date of December 16, 2025. This non-competitive, non-set-aside delivery order represents a routine pharmaceutical procurement to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,905.81 for Azathioprine 50 mg tablets (100-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F65D0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,588.72 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside competitive award to be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical federal vendor. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Troop Support Medical contract vehicle enables efficient delivery of essential pharmaceutical commodities to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, with the DLA planning to expand the Pharmaceutical Prime Vendor Global Program to potentially include multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/6/26 |